Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05410561
Other study ID # HUM00204315
Secondary ID 1R01AA029400-01
Status Recruiting
Phase N/A
First received
Last updated
Start date November 1, 2022
Est. completion date February 28, 2026

Study information

Verified date May 2024
Source University of Michigan
Contact Carly Brin, LMSW
Phone 734-552-6695
Email brinca@med.umich.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this trial is to test new programs to see if they might help people manage their health and health behaviors related to alcohol use and well-being. The program sessions focus on getting to know what's important to the participants, reviewing or setting goals, and using different skills and behaviors to better manage health. The trial will help the study team learn about ways to deliver health information in a way that is useful and interesting. This research will take place remotely (e.g., Zoom, Facetime, Phone) and participants will be randomized to the Telehealth (TeleTx) group intervention or the Enhanced Usual Care (EUC) control group. Both groups will be asked to have follow-up visits up to 12 months from the baseline visit.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date February 28, 2026
Est. primary completion date February 28, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - Current Diagnostic and Statistical Manual (DSM) -5 alcohol use disorder (AUD) based on alcohol symptom checklist - An average of 3 or more drinking days per week for the past 30 days - Have regular access to a device with video capabilities or a phone to use for study related calls Exclusion Criteria: - Inability to speak or understand English - Conditions that preclude informed consent or understanding of assessment or intervention content - Past 90-day AUD psychotherapy treatment, - At elevated risk for complicated alcohol withdrawal - Past-year drug injection.

Study Design


Intervention

Behavioral:
Enhanced Usual Care (EUC)
EUC will comprise one session of brief psychoeducation and referral information to alcohol use disorder (AUD) treatment.
TeleTx intervention
TeleTx will consist of an initial session and then 8 ~counseling sessions.

Locations

Country Name City State
United States University of Michigan Ann Arbor Michigan
United States VA Ann Arbor Health Care | Veterans Affairs Ann Arbor Michigan

Sponsors (2)

Lead Sponsor Collaborator
University of Michigan National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Alcohol Use Disorder Treatment Initiation Percent of patients who initiate Alcohol Use Disorder psychotherapy treatment 3 months
Primary Alcohol Use Disorder Treatment Engagement Percent of patients who attend at least 2 additional Alcohol Use Disorder psychotherapy sessions 3 months
Primary Alcohol consumption days Percent days of alcohol use on the Timeline Follow Back interview 3-months
Primary Alcohol consumption days Percent days of alcohol use on the Timeline Follow Back interview 6-months
Primary Alcohol consumption days Percent days of alcohol use on the Timeline Follow Back interview 12-months
Primary Heavy drinking days Percent days heavy drinking on the Timeline Follow Back interview 3-months
Primary Heavy drinking days Percent days heavy drinking on the Timeline Follow Back interview 6-months
Primary Heavy drinking days Percent days heavy drinking on the Timeline Follow Back interview 12-months
Secondary Total Alcohol Use Disorder Psychotherapy Treatment Attendance Total number of psychotherapy sessions 6-months
Secondary Total Alcohol Use Disorder Psychotherapy Treatment Attendance Total number of psychotherapy sessions 12-months
Secondary Drinking Risk Levels (Based on World Health Organization Cut-Offs) Change in WHO drinking levels (defined by alcohol consumed per day from 1g to undefined maximum with higher amounts associated with worse outcomes) Baseline to 3-months
Secondary Drinking Risk Levels (Based on World Health Organization Cut-Offs) Change in WHO drinking levels (defined by alcohol consumed per day from 1g to undefined maximum with higher amounts associated with worse outcomes) Baseline to 6-months
Secondary Drinking Risk Levels (Based on World Health Organization Cut-Offs) Change in WHO drinking levels (defined by alcohol consumed per day from 1g to undefined maximum with higher amounts associated with worse outcomes) Baseline to 12-months
Secondary World Health Organization Quality of Life Abbreviated (WHO-QOL-BREF) Change in Quality of Life measure (WHO-QOL BREF). Transformed domain scores from 0 to 100. Higher scores denote better quality of life. Baseline to 3-months
Secondary World Health Organization Quality of Life Abbreviated (WHO-QOL-BREF) Change in Quality of Life measure (WHO-QOL BREF). Transformed domain scores from 0 to 100. Higher scores denote better quality of life. Baseline to 6-months
Secondary World Health Organization Quality of Life Abbreviated (WHO-QOL-BREF) Change in Quality of Life measure (WHO-QOL BREF). Transformed domain scores from 0 to 100. Higher scores denote better quality of life. Baseline to 12-months
Secondary Alcohol consequences Change in alcohol consequences measured by the modified 17-item Short Inventory of Problem-R Baseline to 3-months
Secondary Alcohol consequences Change in alcohol consequences measured by the modified 17-item Short Inventory of Problem-R Baseline to 6-months
Secondary Alcohol consequences Change in alcohol consequences measured by the modified 17-item Short Inventory of Problem-R Baseline to 12-months
See also
  Status Clinical Trial Phase
Completed NCT05660434 - Using Aromatherapy in Substance Use Disorder N/A
Active, not recruiting NCT05338268 - Substance Use and Loneliness N/A
Completed NCT04098614 - Barriers to Substance Use Disorder Recovery N/A
Completed NCT03954184 - E-health Implementation (Iowa) N/A
Completed NCT03590106 - Cardiac Surgery Peer Recovery Support Program N/A
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Recruiting NCT06273228 - Parenting Young Children in Pediatrics N/A
Recruiting NCT05327504 - Written Exposure Therapy for Veterans With SUD and PTSD N/A
Terminated NCT03517111 - The Impact of a Parenting Intervention on Latino Youth Health Behaviors N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Completed NCT04401215 - Technologically-Augmented Referrals to Mitigate Addiction Consequences N/A
Not yet recruiting NCT06187701 - Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients N/A
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A
Recruiting NCT04296604 - Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations N/A
Active, not recruiting NCT02382042 - Intensive Referral Intervention to Improve Substance Use Disorder Treatment Outcomes Among Rural and Highly Rural Veterans N/A
Terminated NCT01356667 - Drum-Assisted Therapy for Native Americans N/A
Completed NCT01237366 - Study Targeting Affect Regulation Phase 1/Phase 2
Completed NCT00708890 - Twelve Step Based Self-help Groups for Substance Related Disorders N/A
Active, not recruiting NCT04048850 - Zepatier in Patients With Substance Use
Recruiting NCT05976646 - Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion Phase 1/Phase 2